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Abstract
Background: Heparan sulfate proteoglycans modulate signaling by a variety of growth factors.
The mammalian proteoglycan Perlecan binds and regulates signaling by Sonic Hedgehog, Fibroblast
Growth Factors (FGFs), Vascular Endothelial Growth Factor (VEGF) and Platelet Derived Growth
Factor (PDGF), among others, in contexts ranging from angiogenesis and cardiovascular
development to cancer progression. The Drosophila Perlecan homolog trol has been shown to
regulate the activity of Hedgehog and Branchless (an FGF homolog) to control the onset of stem
cell proliferation in the developing brain during first instar. Here we extend analysis of trol mutant
phenotypes to show that trol is required for a variety of developmental events and modulates
signaling by multiple growth factors in different situations.
Results: Different mutations in trol allow developmental progression to varying extents, suggesting
that trol is involved in multiple cell-fate and patterning decisions. Analysis of the initiation of
neuroblast proliferation at second instar demonstrated that trol regulates this event by modulating
signaling by Hedgehog and Branchless, as it does during first instar. Trol protein is distributed over
the surface of the larval brain, near the regulated neuroblasts that reside on the cortical surface.
Mutations in trol also decrease the number of circulating plasmatocytes. This is likely to be due to
decreased expression of pointed, the response gene for VEGF/PDGF signaling that is required for
plasmatocyte proliferation. Trol is found on plasmatocytes, where it could regulate VEGF/PDGF
signaling. Finally, we show that in second instar brains but not third instar brain lobes and eye discs,
mutations in trol affect signaling by Decapentaplegic (a Transforming Growth Factor family
member), Wingless (a Wnt growth factor) and Hedgehog.
Conclusion: These studies extend the known functions of the Drosophila Perlecan homolog trol in
both developmental and signaling contexts. These studies also highlight the fact that Trol function
is not dedicated to a single molecular mechanism, but is capable of regulating different growth
factor pathways depending on the cell-type and event underway.
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Heparan sulfate proteoglycans (HSPGs) are a family of
cell-surface and extracellular proteins modified by the
attachment of glycosaminoglycan chains. The general
structure of the protein core determines the family the
HSPG belongs to: Syndecans contain a transmembrane
domain, Glypicans are tethered to the cell surface via a
GPI linkage and Perlecans are secreted components of the
extracellular matrix. Both the protein core and glycan
chains play important roles in HSPG function through
protein-protein and sugar-protein interactions. Genetic
studies, first in Drosophila and later in mouse and
zebrafish, demonstrated the importance of the heparan
sulfate chains on all three types of HSPGs for signaling by
multiple growth factors such as the Fibroblast Growth
Factors (FGFs), Hedgehogs, Wnts and Transforming
Growth Factors (TGFβs) (reviewed in [1]).
Perlecan is the largest member of the HSPG family with a
core protein of approximately 450kD in size. Perlecan has
been linked to signaling by the heparan-dependent
growth factors FGF2, Vascular Endothelial Growth Factor
(VEGF) and Sonic Hedgehog (SHH) in mammalian sys-
tems (reviewed in [2,3]). Studies of Perlecan knock-out
mice have demonstrated roles for Perlecan in vascular
development and chondrogenesis as well as maintenance
of basement membrane integrity [4-7]. Additional mam-
malian studies have revealed Perlecan's functions in ang-
iogenesis and carcinogenesis ([8-11], reviewed in [2,12]).
Mutation of Perlecan in humans leads to the muscle tone
symptoms of Schwartz-Jampel syndrome, possibly
through altered excitability of the neuromuscular junction
and the skeletal abnormalities of Silver-Handmaker syn-
drome, presumably through effects on chondrogenesis
[13-15].
Studies of Perlecan in invertebrate model systems have led
to additional insights into Perlecan function. The single
Perlecan gene in C. elegans is encoded by the unc-52 locus
[16]. Mutations in unc-52 result in embryonic or adult
paralysis due to defects in body wall muscle cells ([16,17],
reviewed in [18]). Mutations in unc-52 also enhance cell
migration defects caused by decreased netrin, FGF, TGFβ
or Wnt signaling. In Drosophila, Perlecan is encoded by the
trol gene on the X chromosome [19,20], which was ini-
tially implicated in the control of stem cell division in the
developing larval brain [21,22]. In the larval brain, trol
promotes the cell cycle progression of mitotically arrested
neuroblasts [23,24] through modulation of FGF and
Hedgehog signaling [19]. These Drosophila studies were
the first to link Perlecan to Hedgehog signaling. More
recently, studies of oogenesis in Drosophila have uncov-
ered a role for Perlecan in the maintenance of epithelial
cell polarity through interactions with the extracellular
matrix receptor Dystroglycan [25].
The many signaling pathways associated with HSPGs in
general and Perlecan in particular led us to ask what other
biological processes may require Perlecan function. We
used a series of trol mutants to investigate several pheno-
types ranging from overall developmental progress to spe-
cific alterations of stem cell division and hemocyte
production. Furthermore, analysis of signaling pathway
response genes revealed that while mutations in Perlecan
decrease signaling in multiple pathways, at least some of
these effects are tissue specific.
Results and discussion
Development and lethal phase
We had previously shown that the viable trolb22 and the
lethal trol8, trol4, and trolsd alleles form an allelic series of
increasing severity based on their onset of neuroblast pro-
liferation phenotype in first instar larval brain lobes [24].
Identification [19] and phenotypic analysis of a fifth trol
allele, trol7, revealed that trol7 is the strongest allele with
respect to the first instar proliferation phenotype (Fig.
1A). Unexpectedly, trol7 mutant larvae appeared healthier
overall than other trol mutant larvae, suggesting that the
order of allelic severity determined by analysis of first
instar brain lobes would be different from one based on
developmental progression. To test this hypothesis, we
examined the lethal stage and developmental progression
of larvae mutant for trolb22, trol8, trol4, trolsd and trol7. In all
the experiments, crosses were designed to use sibling con-
trols in order to minimize the effects of genetic back-
ground, which can be significant in fly stocks kept in
reproductive isolation from each other for years in our
laboratory. For the lethal trol alleles, y trolx /Binsn stocks
were used as the source of mutant and control larvae. At
this stage of first instar, mutations in y produce one of the
few reliable phenotypic markers. Thus trol mutant animals
were identified as y mutant larvae that are y trolx
hemizygous males and sibling controls were a mixed pop-
ulation of y+ animals: y trolx/Binsn heterozygotes, Binsn
homozygous females and Binsn hemizygous males. Note
that while Binsn homozygous females and hemizygous
males can become viable adults, not all Binsn/Binsn or
Binsn/Y larvae reach adulthood. Thus our comparison
provides a measure of developmental progression and
lethal phase that will err on the side of minimizing the trol
mutant phenotype. For analysis of the viable trolb22 allele,
additional crosses were required to produce wild-type sib-
ling controls from the homozygous y trolb22 stock. y trolb22
animals were crossed to the wild-type strain Canton Spe-
cial (CS) to produce trolb22/CS heterozygous females.
These females were mated to CS males to generate
hemizygous y trolb22 male larvae and y+ sibling control lar-
vae (a mixture of heterozygous y trolb22/CS female,
homozygous CS female and hemizygous CS male) for the
developmental studies. One hundred mutant and sibling
control animals for each allele were collected at early firstPage 2 of 14
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mental progression and viability. Of these, only 1 mutant
trol4 and no trolsd animals pupariated. However, when the
same numbers of trolb22, trol8 and trol7 mutant larvae were
analyzed and compared to sibling controls, 102%, 38%
and 23% of the animals were able to pupariate, respec-
tively (Fig. 1B). The pupariation assay resulted in shifts of
perceived functional severity for both trol4 and trol7, with
trol4 appearing stronger and trol7 appearing weaker.
Why would animals mutant for trol7 (that has a strong
effect on neuroblast proliferation) be able to progress fur-
ther in development than animals mutant for trol4 which
causes a weaker neuroblast proliferation phenotype? One
possibility is that trol modulates the activity of different
signaling pathways in different tissues. For example, a
mutation that affects the ability of Trol to function in the
Hh pathway would have a severe effect on developmental
decisions that require Hh activity and very little effect on
decisions that do not require Hh signaling. To address this
possibility we investigated the impact of trol mutations on
two distinct developmental events and several signaling
pathways.
Effects of trol mutations on TNb proliferation
trol was initially identified as a mutation on the X chromo-
some that affected the proliferation pattern of neuroblasts
in the brain lobes and ventral ganglion [21,22]. Since neu-
roblasts in the thoracic region of the ventral ganglion
begin proliferation in early second instar [21,26,27], we
evaluated the ability of thoracic neuroblasts (TNbs) to
enter S phase in trol mutant animals. We adapted the idea
of phenotypic classes to produce a scale for the extent of
TNb proliferation at four hours post molt (Fig. 1C–G).
Five TNb classes were defined as follows: Class 1, no neu-
roblasts labeled; Class 2, a small number of labeled neu-
roblasts with no distinct segmental pattern; Class 3,
labeled neuroblasts in a segmentally repeated lines with
very few labeled neuroblasts in between the lines or in the
medial region of the ventral ganglion; Class 4, labeled
neuroblasts in a segmentally repeated line with some
labeled neuroblasts in between the lines or in the medial
region of the ventral ganglion; and Class 5, labeled neu-
roblasts in heavily populated segmental pattern with
many labeled neuroblasts in the medial portion of the
ventral ganglion. When both sides of a ventral ganglion
did not conform to a single class, the sample was scored
as the higher class. This will have a conservative effect of
scoring a partial loss-of-proliferation TNb phenotype as
more wild-type. Thus we can have greater confidence in
the significance of TNb proliferation phenotypes observed
compared to controls.
We first examined the onset of TNb proliferation in wild-
type sibling controls to determine the time point at which
to assay the trol mutants (data not shown). In our hands,
high levels of 5-Bromodeoxyuridine (BrdU)-labeled TNbs
were first observed in control samples between 2–5 hours
post molt depending on genetic background. This timing
is slightly earlier than the previous observation that TNb
mitosis begins between 28–34 hours post hatching, or 4–
10 hours post molt (pm) to second instar [26]. To evalu-
ate the TNb proliferation phenotype produced by the dif-
ferent trol alleles, at least twenty samples for each mutant
and sibling control (generated as described above) were
allowed to incorporate BrdU from 4–5 hours pm and
scored for TNb class. The average score and standard error
of the mean were calculated for each group of sibling con-
trols. The control value for each study was set to a value of
4 to control for genetic background effects between exper-
iments. Setting controls to a value of 4 on our 5 point
scale was chosen to allow evaluation of over-proliferation
(>4) as well as under-proliferation (<4) mutant pheno-
types. To obtain the TNb phenotype score for each mutant
allele we normalized the score for each sample to the
respective sibling control and calculated the average and
standard error of the mean (Table 1). Surprisingly, trolb22
mutants had a significantly higher than normal level of
TNb proliferation (TNb score >4) while the remaining trol
mutants showed decreased TNb cell division compared to
controls. The differences between mutant and control
BrdU incorporation were statistically significant (p <
0.05) for each mutant allele. Comparison between
mutants showed a phenotypic trend from trolb22 having
hyperactive TNb proliferation to trolsd as the mutant with
the fewest labeled TNbs. In this assay trol7 mutants appear
to have a weaker phenotype than trolsd.
trol affects Bnl and Hh signaling in the ventral ganglia
To determine if trol affects TNb proliferation through
modulation of Bnl and Hh signaling, we used genetic
interaction studies with the weak trol allele trolb22. As we
have shown, trolb22 animals have over proliferation of
TNbs compared to sibling controls (Table 1). For the
genetic interaction assay, y trolb22 females were crossed to
bnl06916/TM3y+ males to generate y larvae that were y trolb22
; bnl06916/+ and y+ sibling controls that were a combina-
tion of y trolb22 ; +/TM3y+ males, y trolb22/+ ; +/TM3y+
females and trolb22/+ ; bnl06916/+ females. None of the sib-
ling controls had TNb proliferation scores outside of the
normal (CS) range at this timepoint. y trolb22 males carry-
ing a single copy of the bnl06916 allele had fewer BrdU
labeled TNbs at 2–3 hours post molt to second instar
(pm) compared to siblings that were hemizygous or het-
erozygous for trolb22 alone or heterozygous for both trolb22
and bnl06916 (Fig. 2). The decreased TNb proliferation in
samples heterozygous for bnl06916 in a trolb22 background
compared to controls versus the increased proliferation in
trolb22 animals wild-type for bnl compared to controls sug-Page 3 of 14
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Phenotypic series of trol allelesFigure 1
Phenotypic series of trol alleles. A) First instar neuroblast proliferation phenotype presented as % of samples with numbers 
of BrdU labeled neuroblasts falling within the control range, some data originally published in Park et al, 2003a. B) Lethal phase 
phenotype presented as the percentage of trol mutant animals capable of survival and development to third instar (grey bars) or 
to pupal formation (black bars) compared to sibling controls. Error bars indicate s.e.m. C) Cartoon of second instar larval brain 
with dividing TNBs in ventral ganglion. Boxed area indicates portion of brain shown in panels D-G below. A = anterior, P = 
posterior. D-G) Examples of the five classes of BrdU incorporation into TNbs are shown. In all panels anterior is to the left, 
posterior is to the right. Scale bar in panel D indicates 25 um. D) None (class 1). E) Few (class 2). F) Segmentally repeated lines 
with few extra neuroblasts (class 3). G) Segmentally repeated lines with several scattered neuroblasts (class 4). H) Heavily pop-
ulated segmental pattern (class 5).
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the ventral ganglion at second instar.
We also used genetic interactions to evaluate the possibil-
ity that trol might affect Hedgehog signaling in the ventral
ganglion. For this study y trolb22 females were crossed to
hhAC /TM3y+ males to generate y larvae that were y trolb22 ;
hhAC/+ and y+ sibling controls that were a combination of
y trolb22 ; +/TM3y+ males, y trolb22/+ ; +/TM3y+ females and
trolb22/+ ; hhAC /+ females. trolb22 animals carried a single
copy of the hhAC allele, also had fewer dividing TNbs at 2–
3 hours pm compared to sibling controls (Fig. 2). The
decrease in the number of BrdU labeled TNbs in trolb22
hemizygotes upon heterozygosity for hhAC suggest that
mutations in trol also weaken the signaling action of Hh
in the ventral ganglion. To further test our hypotheses, we
examined the signaling activity of Bnl and Hh in trol
mutants directly by quantitative RealTime PCR (qRT-
PCR) in the central nervous system (CNS). To avoid inter-
fering signals from the lobes of the second instar brain
that might overwhelm differences in signal in the ventral
ganglion, we isolated ventral ganglia from second instar
trol mutant and sibling control brains at one hour post
molt. First instar brains were dissected at 20 hours post
hatching which correlates with the end of the BrdU labe-
ling period used to assess neuroblast proliferation in first
instar ([24] and this manuscript). RNA was isolated,
cDNA synthesized and amplified and the level of expres-
sion of the Hh response gene ptc (Fig. 3) and the Bnl
response gene pnt (Fig. 3) assayed. Our qRT-PCR data
demonstrate that mutations in trol affect the strength of
signaling by both Hh and Bnl in the larval ventral gan-
glion and in first instar larval brains (data not shown).
Trol localization in the larval brain
Previously we had isolated complexes containing either
Trol and FGF2 or Trol and Hh by co-immunoprecipitation
[19]. In combination with our genetic studies, these com-
plexes suggested that the Trol protein regulates neuroblast
division by binding growth factors that stimulate neurob-
last proliferation in a manner similar to Perlecan-medi-
ated promotion of ligand-receptor binding described in
mammalian systems [28]. This model predicts that Trol
protein should be localized near the regulated neurob-
lasts, i.e. the optic lobe and central brain neuroblasts of
Trol modulates Hh and Bnl signaling in the ventral ganglionFigure 2
Trol modulates Hh and Bnl signaling in the ventral ganglion. A) Cartoon of second instar brain indicating location of 
TNbs. Boxed area outlines thoracic region shown in panels B-E. One hour BrdU incorporation in TNbs in B) a y trolb22; bnl06916/
+ brain from 2–3 hours pm; C) a sibling control y trolb22/+ ; +/TM3y+, y trolb22 ; +/TM3y+ or y trolb22/+ ; bnl06916/+ brain 2–3 hours 
pm (see text); D) a y trolb22; hhAC/+ brain from 2–3 hours pm and a E) sibling control y trolb22/+ ; +/TM3y+, y trolb22 ; +/TM3y+ or 
y trolb22/+ ; hhAC /+ brain from 2–3 hours pm (see text). Scale bar in panel A indicates 10 um.
Table 1: TNb BrdU incorporation phenotype of trol mutants at 
4–5 hours pm.
trol allele TNb score* S.E.M.
Control 4.00 0.27
trolb22 4.55 0.16
trol8 3.37 0.21
trol4 3.00 0.27
trol7 2.95 0.2
trolsd 2.45 0.21
* All scores significantly different from controls at p < 0.05.Page 5 of 14
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the second instar brain ([22] and Fig. 4A). In contrast, in
situ hybridization studies in the third instar larval brain by
Voigt et al [20] had revealed that only a few isolated cells
at a distance from the optic lobe proliferation centers
express trol. This led the authors to suggest that Trol is
unlikely to regulate neuroblast proliferation by promot-
ing binding of FGF-type ligands to their receptors since
this would require Trol protein localization near the
responding cells. However, since Trol is a secreted protein
with a long half-life, mRNA expression patterns may not
accurately portray protein localization. In addition, Voigt
et al conducted their in situ analysis at late third instar, 2–
3 days after the activation of neuroblast division at late
first or early second instar. Thus the expression pattern
observed for trol message at late third instar may not
reflect expression of trol at earlier larval stages. Further-
more, a study of trol mRNA localization by in situ hybrid-
ization in embryos showed either no obvious staining in
the CNS [30] or expression in a small subset of glial cells
in the CNS [20]. However, analysis of Trol protein locali-
zation with an anti-Trol antibody in embryos revealed
localization to the basement membrane of the CNS [30].
This evidence further suggests that trol message patterns
may not reflect Trol protein localization. To address the
conflicting models, we took advantage of a Trol protein
trap in which the GFP gene is inserted within the endog-
enous trol locus [31]. Analysis of GFP localization in larval
brains demonstrates that Trol-GFP is found in a layer, pre-
sumably the basal lamina, encompassing the entire outer
surface of the larval brain with little to no signal detecta-
ble at internal sites within the brain (Fig. 4B–E). Trol-GFP
was also observed in the basal lamina surrounding nerves
emanating from the larval brain. The distribution of Trol
over the entire brain was further verified by immunohis-
tochemistry using an anti-Trol antibody (Fig. 4F). This
localization of the Trol protein is consistent with the
model that Trol binds Bnl and Hh and facilitates their sig-
naling to promote neuroblast proliferation, as the regu-
lated neuroblasts are found at the surface of the cellular
cortex in both the brain lobes and the ventral ganglion
[21,26,32]. To determine if the localization of Trol-GFP to
the basal lamina was unique to the larval brain, we exam-
ined Trol-GFP in the salivary glands. As in our larval brain
studies, Trol-GFP is found on the surface of the gland, pre-
sumably as a component of the basal lamina (Fig. 4G).
Hh and Bnl signaling activity in the ventral ganglion of trol mutant animalsFigure 3
Hh and Bnl signaling activity in the ventral ganglion of trol mutant animals. Quantitative RT-PCR analysis of the 
expression of the Hh response gene ptc (black bars) and the Bnl response gene pnt (grey bars) in the ventral ganglia of trol 
mutant normalized to controls at one hour post molt to second instar. β-actin was used to as an internal control to normalize 
message levels. All analyses were done in triplicate and three different concentrations to ensure samples were within linear 
range of amplification. Error bars indicate standard deviation.Page 6 of 14
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A second system where we thought trol might have an
effect on development is the production of hemocytes
during larval life. A number of studies have elegantly
shown that the larval lymph gland is the source of larval
hemocytes [33]. In the primary lobe of the third instar
lymph gland prohemocytes arise in the medullary zone
while maturing hemocytes are found in the adjacent cor-
tical zone. Hemocytes are then released into the hemol-
ymph and are present as three types of circulating cells:
plasmatocytes (95%), lamellocytes (1–5%) and crystal
cells (rare). Each cell-type has characteristic morphology
and can be easily identified under a compound micro-
scope. Mature circulating larval hemocytes are still under-
going cell division, albeit at a low rate, as shown by
staining of hemocytes with phosphohistone H3, an M
phase marker [34,35]. Expression of an activated Ras
(Rasv12) in circulating hemocytes increases the percentage
of circulating hemocytes that stain for phosphohistone
H3 and results in a 40-fold increase in the number of
hemocytes through activation of the Ras-MAPK pathway
[34]. The Ras-MAPK pathway is activated by Vascular
Endothelial Growth Factor (VEGF) and Platelet Derived
Growth Factor (PDGF) among others. Signaling by mam-
malian homologs of both growth factors has been linked
to mammalian Perlecan [3]. Furthermore, studies of
PDGF/VEGF receptor (PVR) in Drosophila revealed that
PVR is expressed in plasmatocytes and that decreased PVR
function leads to increased hemocyte cell death [33]. Thus
it seemed likely that mutations in trol could decrease
PDGF/VEGF signaling in circulating plasmatocytes, result-
ing in decreased numbers of circulating plasmatocytes in
trol mutants. To address this hypothesis, we determined
the relative number of circulating plasmatocytes in third
instar trolb22 or trol7 and sibling control larvae (Fig. 5A).
Our analysis demonstrates a significant (p < 0.05) drop in
the number of plasmatocytes in trol mutant versus sibling
control larvae.
Trol localization and function in hemocytes
The decrease in the number of circulating plasmatocytes
in trol mutants versus controls suggested that trol might
indeed function to promote Ras-MAPK signaling by
PDGF/VEGF in circulating plasmatocytes. This predicts
that Trol protein would be localized on these plasmato-
cytes. We used Trol-GFP protein trap to examine the plas-
matocytes for the presence or absence of Trol protein.
Fluorescence microscopy revealed that Trol-GFP is indeed
found on circulating plasmatocytes in third instar larvae
(Fig. 5B,C), but not in the lymph gland (data not shown).
This result is consistent with the requirement for Ras-
MAPK activation in plasmatocytes for plasmatocyte pro-
liferation and for PVR in plasmatocytes to avert apoptosis,
and supports the hypothesis that Trol modulates PVR-Ras-
MAPK signaling in plasmatocytes. The ETS-transcription
factor pnt is a MAPK-response gene and will drive plasma-
tocyte proliferation [36]. Therefore we asked if trol mutant
plasmatocytes show decreased levels of pnt compared to
controls. Plasmatocytes were collected by bleeding third
instar trolb22 and trol7 mutant larvae and sibling controls,
RNA was extracted and amplified, and subjected to qRT-
Localization of Trol-GFP in the larval brainFigure 4
Localization of Trol-GFP in the larval brain. A) Schematic of neuroblast position in the larval brain. A = anterior, P = 
posterior, ONbs = optic lobe neuroblasts, CNbs = central brain neuroblasts, TNbs = thoracic neuroblasts. In panels B-F, Ante-
rior is to the left, Posterior is to the right. B) Optical section of Trol-GFP brains at first instar, brain surface, scale bar indicates 
10 um for both panels B and C. C) Trol-GFP localization in first instar internal section. D) Trol-GFP localization in second 
instar internal section, scale bar indicates 15 um. E) Trol-GFP localization in third instar internal section, scale bar indicates 25 
um. F) First instar brain stained with anti-Trol antibody, showing staining over the entire surface of the brain. Scale bar indi-
cates 10 um. G) Trol-GFP localization in internal section of third instar salivary gland. Scale bar indicates 25 um.Page 7 of 14
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Mutations in trol decrease circulating plasmatocyte number and pnt expressionFigure 5
Mutations in trol decrease circulating plasmatocyte number and pnt expression. A) Quantification of circulating 
plasmatocytes in trolb22 and trol7 mutants compared to controls. Each sample consisted of hemolymph pooled from three third 
instar larvae. Five squares were counted for each sample. Each genotype was analyzed in triplicate. B) Brightfield image of plas-
matocytes from Trol-GFP stock. C) Fluorescence image of plasmatocytes from Trol-GFP stock demonstrating presence of 
Trol on plasmatocytes. D) Expression of the VEGF/PDGF response gene pnt in trolb22 and trol7 mutant hemocytes compared to 
sibling controls by qRT-PCR. Samples of hemolymph from three third instar larvae of each genotype were pooled, RNA 
extracted, amplified and analyzed. All reactions were carried out in triplicate at three different template concentrations to 
ensure amplification was in the linear range. β-actin was used as an internal normalization control.
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Dpp, Wg and Hh signaling are affected in trol mutants in second instar brains but not in third instar brain lobes/eye discsFigure 6
Dpp, Wg and Hh signaling are affected in trol mutants in second instar brains but not in third instar brain 
lobes/eye discs. qRT-PCR analysis of A) the expression levels of dpp, its response gene salm, wg and its response gene slp in 
the ventral ganglia of second instar larvae. Data for the Hh response gene ptc is shown in Fig. 3. B) Expression levels of dpp, its 
response gene salm, wg and its response gene slp, hh and its response gene ptc in trolsd mutant third instar brain lobes/eye discs. 
C) Expression of dpp and salm in hsGAL4/+; +/(EP)dad second instar ventral ganglia and hsGAL4 controls. D) Expression of wg 
and slp in hsGAL4/+; +/(EP)sgg second instar ventral ganglia and hsGAL4 controls. In all panels, error bars indicate standard 
error. All reactions were carried out in triplicate at three different template concentrations to ensure amplification was in the 
linear range. β-actin was used as an internal normalization control.
BMC Developmental Biology 2007, 7:121 http://www.biomedcentral.com/1471-213X/7/121PCR analysis. qRT-PCR studies demonstrated that plasma-
tocytes isolated from either trolb22 or trol7 mutants show
decreased expression of pnt compared to controls, further
evidence that trol modulates Ras-MAPK signaling in plas-
matocytes (Fig. 5D).
Trol and other growth factor signaling pathways
Two other growth factor signaling pathways that have
been linked to HSPGs are the wingless (wg/Wnt) and decap-
entaplegic (dpp/TGFβ) signaling pathways. Both of these
pathways are active in the developing Drosophila eye disc
and/or third instar brain along with Hh and Ras-MAPK
signaling [37,38]. To ask if Trol might modulate the Dpp
and Wg pathways we evaluated the expression of dpp and
wg and their target genes spalt major (salm, [39]) and sloppy
paired (slp, [40]), respectively, in second instar ventral gan-
glia and third instar brains and eye discs from trol mutant
larvae by qRT-PCR (Fig. 6A–B). We also assayed expres-
sion of hh and its response gene ptc in third instar brains
and eye discs. In the trolb22 second instar ventral ganglion
we observed a significant drop in the level of both dpp and
wg compared to controls. The trolb22 mutation also
resulted in diminished signaling efficiency by both
growth factors as indicated by a larger drop in the level of
their response genes salm and slp compared to the ligands
themselves. In contrast, the trolsd mutation decreased only
dpp expression, but the efficiency of both dpp and wg sign-
aling was impaired. Thus in the second instar ventral gan-
gion, wild-type function of trol appears to be required for
normal signaling by hh, bnl, dpp and wg (Figs. 3 and 6A).
The decreased expression of dpp and wg in trolb22 mutants
and of dpp in trolsd mutants may be due to secondary
effects on dpp and wg expression caused by the changes in
Hh and Bnl signaling in trol mutants. Alternatively,
decreased expression of dpp and wg could be due to posi-
tive feedback between Dpp signaling and dpp expression
and Wg signaling and wg expression, respectively. To test
the latter possibility, we blocked Dpp signaling by over-
expression of daughters against dpp (dad) [41], and assayed
for dpp message levels (Fig. 6C). (EP)dad females were
crossed to hsGAL4 males to drive expression of dad.
Embryogenesis and first instar larval development were
carried out at 18°C to limit expression of dad and inhibi-
tion of Dpp signaling at early stages. Upon molt to second
instar, larvae were moved to 25°C for one hour to induce
expression of dad. Larval brains were dissected and the
ventral ganglia harvested for RNA isolations. Inhibition of
Dpp signaling was confirmed by analysis of salm mRNA
levels. Similarly, we inhibited Wg signaling by over-
expression of shaggy (sgg), and assayed for wg message lev-
els (Fig. 6D). Decreased Wg signaling was verified by anal-
ysis of slp expression levels. As shown by our qRT-PCR
analysis, inhibition of Dpp signaling by over-expression
of dad resulted in a drop in expression of the dpp ligand
itself. Inhibition of Wg signaling by over-expression of sgg
also produced a drop in the expression of wg. As these
studies were conducted in flies wild-type for trol, they
eliminate the possibility that the decreased expression of
dpp and wg in trol mutants was due solely to reduced Trol-
mediated signaling by Hh and/or Bnl. These data indicate
the presence of a positive feedback loop for Dpp and Wg
in the ventral ganglion.
To determine if Trol is necessary for growth factor signal-
ing in other tissues at other stages we assayed for dpp, wg
and hh expression and activity in trolb22 and trolsd third
instar brain lobes and eye discs. No significant changes in
either growth factor expression or signaling were observed
in trolb22 samples (data not shown). In trolsd samples,
expression of all three growth factors decreased by 65–
85%, as did the expression of their response genes (Fig.
6B). The sole exception is wg/slp, where wg expression
decreased about 65% and slp expression decreased only
about 50%. These data indicate that mutations in trol do
not dramatically decrease the signaling efficiency of Dpp,
Wg or Hh in third instar brain lobes and eye discs, unlike
the effect of those same trol mutations in second instar.
Conclusion
trol and Drosophila development
We have previously demonstrated that mutations in trol
prevent the onset of neuroblast division in the first instar
brain and that most trol mutations are lethal. Mutations in
a second gene, anachronism, also affect the onset of neu-
roblast proliferation but in the opposite manner: in anach-
ronism mutants, mitotically regulated neuroblasts begin
cell division too early [42]. However, when a lethal trol
mutation was combined with a viable allele of anachro-
nism, the lack of neuroblast division was rescued (double
mutants exhibited the anachronism phenotype of prema-
ture neuroblast division) but lethality was not [21]. This
outcome suggested that trol function is required for other
developmental events necessary for survival. Further anal-
yses revealed that trol modulates Hh and Bnl signaling in
the first instar brain [19]. Here we have demonstrated that
trol function is required for developmental progression to
third instar and for pupariation. Analogous to its function
in the first instar brain, trol is required to initiate the divi-
sion of a second, independent and spatially distinct pop-
ulation of neuroblasts in the second instar brain (Table 1,
Fig. 1). This initiation of division is also dependent on Bnl
and Hh signaling (Fig. 2). We have also demonstrated that
the Trol protein is localized to the surface of the brain at
all larval stages, which places it in close proximity to the
regulated neuroblasts. This localization is consistent with
our model where Trol regulates Bnl and Hh signaling to
cells adjacent to the regulated neuroblasts by binding the
growth factors directly [19]. Trol protein localization to
the basal lamina is not limited to the larval brain, as Trol-
GFP studies also showed Trol protein in the basal laminaPage 10 of 14
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not limited to the nervous system, as mutations in trol also
diminish the number of circulating plasmatocytes by
decreasing expression of pnt, a PVR response gene in plas-
matocytes (Fig. 5). We speculate that trol may be necessary
for signaling by the Drosophila PDGF and/or VEGF growth
factor, just as mammalian Perlecan has been shown to
function during angiogenesis [3]. Our studies of Dpp and
Wg indicate a positive feedback between dpp expression
and Dpp signaling and wg expression and Wg signaling in
the second instar ventral ganglion. Signaling by Dpp and
Wg is also dependent on trol in the second instar brain,
but not (or very little) in the third instar brain lobes and
eye discs (Fig. 6), despite the fact that Dpp and Wg signal-
ing are taking place in those tissues. In fact, even Hh sign-
aling appears to be independent of trol in this context.
These results highlight an important concept in trol, and
indeed, in proteoglycan function: that the Trol protein
will be used at different times and places to regulate the
signaling of different growth factors. Deciphering the role
of trol in different developmental decisions will require
that we examine each event individually, as trol will not
necessarily mediate the same molecular mechanism each
time.
Involvement of HSPGs in growth factor signaling
The requirement for heparan sulfate proteoglycans in sig-
naling by different families of growth factors is well estab-
lished [43], but what is not yet clear is why different
organs and tissue types use different HSPGs to modulate
these signaling pathways. One possibility is that the spe-
cific mechanism(s) through which these molecules mod-
ulate signaling activity allows for site-specific variations in
the regulation of signaling activity. HSPGs with varied
amino acid sequence can act in the same signaling path-
way, such as Syndecan-4 and Perlecan for FGF2 [28,44] or
Glypicans, Syndecan-3 and Perlecan for Hh [19,43,45].
Mutations that affect heparan sulfate synthesis or modifi-
cation strongly affect FGF2 and Hh signaling [43]. Fur-
thermore, Perlecan isolated from various endothelial cell
sources has different binding affinities for FGF2 [46].
These data initially suggested that the protein core of the
HSPG might have little to do with signaling specificity and
that the main functional domain of HSPGs is concen-
trated in the sequence of the heparan sulfate chains.
The carbohydrate-centric view is being challenged by
studies that indicate a role for the protein-protein interac-
tions of HSPGs with growth factors and other signaling
molecules. For example, expression of chimeric molecules
has shown that the cytoplasmic tail of Syndecan is specif-
ically required for FGF2 signaling in addition to its
heparan sulfate chains [47]. Perlecan protein-protein
interactions include the ability of Perlecan to bind growth
factors and extracellular matrix molecules at various sites
on its protein core. Further mechanisms that allow for dif-
ferential regulation include processing of HSPGs. These
studies suggest a reason for the use of a particular HSPG
during an individual developmental decision – the flexi-
bility of combining both carbohydrate-based regulation
and protein-based regulation of cell-cell signaling may
make a specific HSPG uniquely suited for a given situa-
tion.
In the context of combined carbohydrate and protein
inputs into HSPG function, it becomes clear that a given
HSPG may be expressed and function in very specific con-
texts that take advantage of its unique regulatory abilities.
It is interesting to note that we have connected Perlecan
with FGF and Hh signaling in the developing fly brain
while mouse studies have shown that Perlecan knock-out
mice have cerebral cortex abnormalities [6,19,21]. trol
mutant larvae have decreased numbers of circulating
hemocytes that are likely due to decreased Ras-MAPK sig-
naling by VEGF/PDGF. Perlecan knock-out mice also have
defects in chondrogenesis and cardiovascular develop-
ment and mammalian studies have demonstrated a role
for Perlecan in angiogenesis driven by FGFs, VEGF and
PDGF [3]. Finally, we have shown that Perlecan is
required for SHH signaling during human prostate cancer
growth [8], which reveals a new system for the investiga-
tion of the mechanism of Perlecan action. Further analysis
of the ability of HSPGs to substitute for each other in cell
fate decisions and the means by which they individually
regulate cell-cell communication will lead to a clearer
understanding of the inputs necessary for cells to carry out
a developmental or disease progression.
Methods
Fly stocks
Stocks of the viable trolb22 allele and the lethal trol4, trol7,
trol8 and trolsd alleles have been described previously
[19,21,22,29]. All trol mutant stocks with the exception of
trolb22 are y trolxw/Binsn where the chromosome carrying
the trol mutation is marked with y to facilitate identifica-
tion of y trol mutant versus y+control larvae. The trol-GFP
protein trap was obtained from Dr. Stephane Noselli. The
bnl06916 and hhAC stocks were obtained from the Bloom-
ington stock center and used to construct y ; bnl06916/
TM3y+ and y ; hhAC/TM3y+ stocks for genetic studies.
Lethal phase
Early first instar larvae were collected and placed on apple
juice plates with yeast. Each plate initially had 50 mutant
or control animals per plate, segregated to prevent compe-
tition between mutant and wildtype siblings. Two plates
of each genotype were examined. The number and stage of
larvae still present on each plate were assayed every 24
hours and the survivors transferred to a fresh plate. Since
none of the trol mutants with the exception of trolb22 pro-Page 11 of 14
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Developmental staging
Developmental synchronization was carried out as previ-
ously described [19,21,23,48]. Flies were allowed to lay
eggs on apple juice agar plates with fresh yeast overnight
or for about 24 hours. For staging of synchronized first
instar larvae, the plate was first cleared of any larvae and
newly hatched larvae collected in one hour windows and
placed on new apple juice plates with yeast at 25°C for
aging. For staging of second instar larvae, late first instar
larvae were placed on fresh apple juice plates with yeast.
Newly molted second instars were collected in one hour
windows and placed on apple juice plates with yeast at
25°C for aging or dissected immediately.
Proliferation assay
BrdU assays were carried out as previously described
[19,21,23,48]. Briefly, animals were fed BrdU-containing
artificial medium for one hour, dissected in PBST and
fixed with Histochoice (Amresco) for 10 minutes. Brain
samples were denatured in PBST-HCl for 30 minutes,
washed and blocked in PBNT for one hour. Primary anti-
BrdU antibody (Becton-Dickinson) was added at 1:200
overnight at 4°C. Samples were washed and incubated
with HRP-conjugated secondary antibody at 1:400 for 2–
4 hours at room temperature. Signal was developed using
a DAB substrate (Sigma).
Larval hemocyte assay
Hemocytes from three third instar larvae were harvested
using a Pasteur pipette pulled to generate a capillary end,
pooled and counted on a standard hemacytometer slide.
Five 16-square regions were counted for each pooled sam-
ple. Three replicates were assayed for each genotype.
Quantitative RealTime PCR
Whole first instar brains or ventral ganglia dissected from
the brains of second instar larvae were used for RNA iso-
lation. For first instar brain samples, total RNA was iso-
lated using Trizol (Invitrogen) following manufacturer's
directions. Samples were DNAsed and reverse transcribed
using oligo dT primers. The resulting cDNA was used to
perform quantitative Real Time PCR with SYBR Green
dye. For ventral ganglia isolated during second instar RNA
was extracted and the sequences amplified as described in
[49,50]. Hemocyte studies were carried out on pooled
hemolymph from three third instar larvae per sample.
RNA was extracted and amplified as for ventral ganglia. All
qRT-PCR reactions were carried out in triplicate at three
different template concentrations to ensure that we were
within linear template range. Primer sequences are availa-
ble upon request. β-actin expression was used as an inter-
nal control. Data were analyzed using the delta-delta
calculation method to yield fold change compared to con-
trols.
Statistics
Determination of significance was accomplished by use of
Student's t test or ANOVA, depending on the design of the
study.
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